Global Anti-Depressant market is expected to grow from US$ 15440 million in 2025 to US$ 18900 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Global Anti-Depressant Market Size and Outlook 2025-31

The global Anti-Depressant market size is predicted to grow from US$ 15440 million in 2025 to US$ 18900 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessivecompulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Anti-Depressant Industry Forecast looks at past sales and reviews total world Anti-Depressant sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Depressant sales for 2025 through 2031. With Anti-Depressant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Depressant industry. This Insight Report provides a comprehensive analysis of the global Anti-Depressant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Depressant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Anti-Depressant market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Depressant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Depressant. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Depressant market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Tricyclic Antidepressants &nbsp;&nbsp;&nbsp; Selective Serotonin Reuptake Inhibitors &nbsp;&nbsp;&nbsp; Serotonin-Norepinephrine Reuptake Inhibitors &nbsp;&nbsp;&nbsp; Monoamine Oxidase Inhibitors &nbsp;&nbsp;&nbsp; Serotonin Antagonist &nbsp;&nbsp;&nbsp; Reuptake Inhibitors &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Major Depressive Disorder &nbsp;&nbsp;&nbsp; Obsessive-Compulsive Disorder &nbsp;&nbsp;&nbsp; Generalized Anxiety Disorder &nbsp;&nbsp;&nbsp; Panic Disorder &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Alkermes &nbsp;&nbsp;&nbsp; Allergan &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Eli Lilly and Company &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Lundbeck &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries &nbsp;&nbsp;&nbsp; Takeda Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Anti-Depressant market? What factors are driving Anti-Depressant market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Anti-Depressant market opportunities vary by end market size? How does Anti-Depressant break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Anti-Depressant Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Anti-Depressant by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Anti-Depressant by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Anti-Depressant Segment by Type &nbsp;2.2.1 Tricyclic Antidepressants &nbsp;2.2.2 Selective Serotonin Reuptake Inhibitors &nbsp;2.2.3 Serotonin-Norepinephrine Reuptake Inhibitors &nbsp;2.2.4 Monoamine Oxidase Inhibitors &nbsp;2.2.5 Serotonin Antagonist &nbsp;2.2.6 Reuptake Inhibitors &nbsp;2.2.7 Others &nbsp;2.3 Anti-Depressant Sales by Type &nbsp;2.3.1 Global Anti-Depressant Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Anti-Depressant Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Anti-Depressant Sale Price by Type (2020-2025) &nbsp;2.4 Anti-Depressant Segment by Application &nbsp;2.4.1 Major Depressive Disorder &nbsp;2.4.2 Obsessive-Compulsive Disorder &nbsp;2.4.3 Generalized Anxiety Disorder &nbsp;2.4.4 Panic Disorder &nbsp;2.4.5 Others &nbsp;2.5 Anti-Depressant Sales by Application &nbsp;2.5.1 Global Anti-Depressant Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Anti-Depressant Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Anti-Depressant Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Anti-Depressant Breakdown Data by Company &nbsp;3.1.1 Global Anti-Depressant Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Anti-Depressant Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Anti-Depressant Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Anti-Depressant Revenue by Company (2020-2025) &nbsp;3.2.2 Global Anti-Depressant Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Anti-Depressant Sale Price by Company &nbsp;3.4 Key Manufacturers Anti-Depressant Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Anti-Depressant Product Location Distribution &nbsp;3.4.2 Players Anti-Depressant Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Anti-Depressant by Geographic Region &nbsp;4.1 World Historic Anti-Depressant Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Anti-Depressant Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Anti-Depressant Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Anti-Depressant Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Anti-Depressant Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Anti-Depressant Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Anti-Depressant Sales Growth &nbsp;4.4 APAC Anti-Depressant Sales Growth &nbsp;4.5 Europe Anti-Depressant Sales Growth &nbsp;4.6 Middle East & Africa Anti-Depressant Sales Growth 5 Americas &nbsp;5.1 Americas Anti-Depressant Sales by Country &nbsp;5.1.1 Americas Anti-Depressant Sales by Country (2020-2025) &nbsp;5.1.2 Americas Anti-Depressant Revenue by Country (2020-2025) &nbsp;5.2 Americas Anti-Depressant Sales by Type (2020-2025) &nbsp;5.3 Americas Anti-Depressant Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Anti-Depressant Sales by Region &nbsp;6.1.1 APAC Anti-Depressant Sales by Region (2020-2025) &nbsp;6.1.2 APAC Anti-Depressant Revenue by Region (2020-2025) &nbsp;6.2 APAC Anti-Depressant Sales by Type (2020-2025) &nbsp;6.3 APAC Anti-Depressant Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Anti-Depressant by Country &nbsp;7.1.1 Europe Anti-Depressant Sales by Country (2020-2025) &nbsp;7.1.2 Europe Anti-Depressant Revenue by Country (2020-2025) &nbsp;7.2 Europe Anti-Depressant Sales by Type (2020-2025) &nbsp;7.3 Europe Anti-Depressant Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Anti-Depressant by Country &nbsp;8.1.1 Middle East & Africa Anti-Depressant Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Anti-Depressant Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Anti-Depressant Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Anti-Depressant Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Anti-Depressant &nbsp;10.3 Manufacturing Process Analysis of Anti-Depressant &nbsp;10.4 Industry Chain Structure of Anti-Depressant 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Anti-Depressant Distributors &nbsp;11.3 Anti-Depressant Customer 12 World Forecast Review for Anti-Depressant by Geographic Region &nbsp;12.1 Global Anti-Depressant Market Size Forecast by Region &nbsp;12.1.1 Global Anti-Depressant Forecast by Region (2026-2031) &nbsp;12.1.2 Global Anti-Depressant Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Anti-Depressant Forecast by Type (2026-2031) &nbsp;12.7 Global Anti-Depressant Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Alkermes &nbsp;13.1.1 Alkermes Company Information &nbsp;13.1.2 Alkermes Anti-Depressant Product Portfolios and Specifications &nbsp;13.1.3 Alkermes Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Alkermes Main Business Overview &nbsp;13.1.5 Alkermes Latest Developments &nbsp;13.2 Allergan &nbsp;13.2.1 Allergan Company Information &nbsp;13.2.2 Allergan Anti-Depressant Product Portfolios and Specifications &nbsp;13.2.3 Allergan Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Allergan Main Business Overview &nbsp;13.2.5 Allergan Latest Developments &nbsp;13.3 Bristol-Myers Squibb &nbsp;13.3.1 Bristol-Myers Squibb Company Information &nbsp;13.3.2 Bristol-Myers Squibb Anti-Depressant Product Portfolios and Specifications &nbsp;13.3.3 Bristol-Myers Squibb Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Bristol-Myers Squibb Main Business Overview &nbsp;13.3.5 Bristol-Myers Squibb Latest Developments &nbsp;13.4 Eli Lilly and Company &nbsp;13.4.1 Eli Lilly and Company Company Information &nbsp;13.4.2 Eli Lilly and Company Anti-Depressant Product Portfolios and Specifications &nbsp;13.4.3 Eli Lilly and Company Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Eli Lilly and Company Main Business Overview &nbsp;13.4.5 Eli Lilly and Company Latest Developments &nbsp;13.5 GlaxoSmithKline &nbsp;13.5.1 GlaxoSmithKline Company Information &nbsp;13.5.2 GlaxoSmithKline Anti-Depressant Product Portfolios and Specifications &nbsp;13.5.3 GlaxoSmithKline Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 GlaxoSmithKline Main Business Overview &nbsp;13.5.5 GlaxoSmithKline Latest Developments &nbsp;13.6 Lundbeck &nbsp;13.6.1 Lundbeck Company Information &nbsp;13.6.2 Lundbeck Anti-Depressant Product Portfolios and Specifications &nbsp;13.6.3 Lundbeck Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Lundbeck Main Business Overview &nbsp;13.6.5 Lundbeck Latest Developments &nbsp;13.7 Merck &nbsp;13.7.1 Merck Company Information &nbsp;13.7.2 Merck Anti-Depressant Product Portfolios and Specifications &nbsp;13.7.3 Merck Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Merck Main Business Overview &nbsp;13.7.5 Merck Latest Developments &nbsp;13.8 Pfizer &nbsp;13.8.1 Pfizer Company Information &nbsp;13.8.2 Pfizer Anti-Depressant Product Portfolios and Specifications &nbsp;13.8.3 Pfizer Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Pfizer Main Business Overview &nbsp;13.8.5 Pfizer Latest Developments &nbsp;13.9 Teva Pharmaceutical Industries &nbsp;13.9.1 Teva Pharmaceutical Industries Company Information &nbsp;13.9.2 Teva Pharmaceutical Industries Anti-Depressant Product Portfolios and Specifications &nbsp;13.9.3 Teva Pharmaceutical Industries Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Teva Pharmaceutical Industries Main Business Overview &nbsp;13.9.5 Teva Pharmaceutical Industries Latest Developments &nbsp;13.10 Takeda Pharmaceutical &nbsp;13.10.1 Takeda Pharmaceutical Company Information &nbsp;13.10.2 Takeda Pharmaceutical Anti-Depressant Product Portfolios and Specifications &nbsp;13.10.3 Takeda Pharmaceutical Anti-Depressant Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Takeda Pharmaceutical Main Business Overview &nbsp;13.10.5 Takeda Pharmaceutical Latest Developments 14 Research Findings and Conclusion

Report	Global Anti-Depressant Market Growth 2025-2031
Selected License	Single ID:LPI24821

Buyer Information

Order Summary